Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials

@article{DAngelo2016AdjuvantAN,
  title={Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials},
  author={Francesco D’Angelo and Laura Antolino and Mara La Rocca and Niccolo' Petrucciani and Paolo Magistri and Paolo Aurello and Giovanni Ramacciato},
  journal={Medical Oncology},
  year={2016},
  volume={33},
  pages={1-9}
}
The timing of surgery and antineoplastic therapies in patients with resectable non-metastatic pancreatic cancer is still a controversial matter of debate, with special regard to neoadjuvant approaches. Following the criteria of the PRISMA statement, a literature search was conducted looking for RCTs focusing on adjuvant and neoadjuvant therapies in resectable pancreatic cancer. The quality of the available evidence was assessed using the Cochrane Collaboration’s tool for assessing risk of bias… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.
SHOWING 1-7 OF 7 CITATIONS